Outpost Medicine is a biopharmaceutical company focused on the development of novel therapeutics for the treatment of urologic and gastrointestinal disorders. Located in Indianapolis, IN and London, UK, Outpost is a private company launched in 2016 and has raised $61 million in Series A venture capital financing from Frazier Healthcare Partners, Adams Street Partners, Novo Holdings A/S, Vivo Capital and Takeda Ventures.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/15/17 | $20,000,000 | Series A Extension |
Adams Street Partners Frazier Healthcare Novo Holdings Takeda Ventures Vivo Capital | undisclosed |
